Edition:
United States

Novartis AG (NOVN.S)

NOVN.S on Virt-X Level 1

80.80CHF
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
CHF80.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,983,606
52-wk High
CHF88.30
52-wk Low
CHF72.45

Select another date:

Fri, Feb 16 2018

Photo

Novartis readies to auction U.S. generic pills business: sources

Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.

CORRECTED-Novartis readies to auction U.S. generic pills business -sources

Feb 16 Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.

BRIEF-Novartis forms alliance for treating infectious diarrheal disease

* NOVARTIS FORMS ALLIANCE TO DEVELOP MEDICINES FOR TREATING INFECTIOUS DIARRHEAL DISEASE

Novartis gains U.S. approval for delayed MS drug

ZURICH Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.

UPDATE 2-Novartis gains U.S. approval for delayed MS drug

* U.S. pricing pressure weighing on Sandoz (Adds Teva comment, share price reaction)

Novartis gets U.S. approval for bigger dose Glatopa MS treatment

ZURICH, Feb 13 Novartis's Sandoz division said on Tuesday it has won approval in the United States for a larger dosage of its Glatopa treatment for multiple sclerosis patients.

Greek PM wants politicians investigated in alleged Novartis bribery case

ATHENS/ZURICH Greece's prime minister urged parliament on Monday to probe politicians in an alleged drug bribery case, while Swiss drugmaker Novartis promised to take action if an investigation found unethical conduct.

Novartis promises fast, decisive action if wrongdoing found in Greece

ZURICH, Feb 12 Swiss drugmaker Novartis has promised to take "fast and decisive action" should an investigation into alleged bribery in Greece find that its managers engaged in unethical or illegal conduct.

Drugmaker GSK wins fresh Advair reprieve as Novartis copy delayed

LONDON, Feb 8 GlaxoSmithKline has won another reprieve for its blockbuster Advair lung drug after U.S. regulators delayed approval of a generic copy from Novartis's Sandoz division.

BRIEF-Novartis gets U.S. approval for Cosentyx label Update

* NOVARTIS RECEIVES FDA APPROVAL FOR COSENTYX® LABEL UPDATE TO INCLUDE MODERATE-TO-SEVERE SCALP PSORIASIS

Select another date: